- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
January 4th, 2008
Bilcare has acquired Singapore-based Singular ID for 20 million Singapore dollars, reports CNBC-TV18. The latter provides pharma counterfeit solutions.
Bilcare has been looking at advancing its technology, in terms of solutions for counterfeit drugs. Now, it has gone ahead and acquired a Singapore-based company called Singular ID. They had been looking at this particular company for sometime.
Singular ID is a very high technology company, which uses nanotechnology, in terms of developing solutions to minimize the use of counterfeit drugs, which is seen as a big menace for most of the pharmaceutical companies.
|Related News Press|
Law enforcement/Anti-Counterfeiting/Security/Loss prevention
Nanotech Grants Options September 22nd, 2016
NIST Patents Single-Photon Detector for Potential Encryption and Sensing Apps September 16th, 2016
New nanomedicine approach aims to improve HIV drug therapies October 24th, 2016
Keysight Technologies Begins Trading as Independent Company November 3rd, 2014